Hongqi Xue

A Phase 1 Clinical Study Evaluating the Effects of Cenobamate on the QT Interval

Börje Darpö, Philip T. Sager, Hongqi Xue et al. · Clinical Pharmacology in Drug Development · 2022 · 18 citations

Medicine, Pharmacology, Pharmacotherapy +14

Intravenous Amisulpride Does Not Meaningfully Prolong the QTc Interval at Doses Effective for the Management of Postoperative Nausea and Vomiting

Gabriel Fox, Muna Albayaty, Joanna Walker et al. · Anesthesia & Analgesia · 2019 · 15 citations

Nursing, Pharmacology, Pharmacotherapy +13

Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study

Lei Sun, Sergey Yagoda, Hongqi Xue et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2020 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study

Marie T. Borin, Chris N. Barnes, Börje Darpö et al. · Clinical Pharmacology in Drug Development · 2019 · 13 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Safety, Pharmacokinetics, and Pharmacodynamics of Trazpiroben (TAK‐906), a Novel Selective D₂/D₃ Receptor Antagonist: A Phase 1 Randomized, Placebo‐Controlled Single‐ and Multiple‐Dose Escalation Study in Healthy Participants

R.L. Whiting, Börje Darpö, Chunlin Chen et al. · Clinical Pharmacology in Drug Development · 2021 · 13 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13